feed,title,long_url,short_url
SeekingAlpha,"Griffon concludes strategic alternatives review, increases share repurchase program",https://seekingalpha.com/news/3958307,
SeekingAlpha,Aquestive receives conditional FDA approval for proprietary name Anaphylm for lead candidate AQST-109,https://seekingalpha.com/news/3958306,
SeekingAlpha,Acutus Medical gives prelim Q1 reports,https://seekingalpha.com/news/3958305,
